FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Douglas Robinson

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Procedures

Physiology

Lymphocyte Activation

Co-author Network

Publications

TOP 3
Douglas S Robinson
Mepolizumab for severe eosinophilic asthma.
Douglas S Robinson
Mepolizumab treatment for asthma.
Harsha H Kariyawasam; Douglas S Robinson; M Semitekolou; Georgina Xanthou
Activin-A: a novel critical regulator of allergic asthma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Douglas Robinson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Douglas S Robinson
Mepolizumab for severe eosinophilic asthma.
Expert review of respiratory medicine 2013;7(1):13-7.
2013: Douglas S Robinson
Mepolizumab treatment for asthma.
Expert opinion on biological therapy 2013;13(2):295-302.
2011: Harsha H Kariyawasam; Douglas S Robinson; M Semitekolou; Georgina Xanthou
Activin-A: a novel critical regulator of allergic asthma.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2011;41(11):1505-14.
2011: Douglas S Robinson
Utility of inhaled allergen challenge in clinical diagnosis and management of asthma: what never? Well, hardly ever!
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2011;41(5):606-8.
2010: G Banfield; H Watanabe; Glenis Scadding; Mikila R Jacobson; Stephen Till; D A Hall; Douglas S Robinson; Clare M Lloyd; Kayhan T Nouri-Aria; Stephen R Durham
CC chemokine receptor 4 (CCR4) in human allergen-induced late nasal responses.
Allergy 2010;65(9):1126-33.
2009: A E Anderson; K J Mackerness; M Aizen; V A Carr; D Nguyen; F Du Pre; S R Durham; Douglas S Robinson
Seasonal changes in suppressive capacity of CD4+ CD25+ T cells from patients with hayfever are allergen-specific and may result in part from expansion of effector T cells among the CD25+ population.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2009;39(11):1693-9.
2009: Harsha H Kariyawasam; Sophie Pegorier; Julia Barkans; Georgina Xanthou; Maxine Aizen; Sun Ying; A Barry Kay; Clare M Lloyd; Douglas S Robinson
Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthma.
The Journal of allergy and clinical immunology 2009;124(3):454-62.
2009: Maria Semitekolou; Themis Alissafi; Maria Aggelakopoulou; Evangelia Kourepini; Harsha H Kariyawasam; Antony B Kay; Douglas S Robinson; Clare M Lloyd; Vily Panoutsakopoulou; Georgina Xanthou
Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease.
The Journal of experimental medicine 2009;206(8):1769-85.
2009: D Ahern; Clare M Lloyd; Douglas S Robinson
Chemokine responsiveness of CD4+ CD25+ regulatory and CD4+ CD25- T cells from atopic and nonatopic donors.
Allergy 2009;64(8):1121-9.
2008: Jennifer Kearley; Douglas S Robinson; Clare M Lloyd
CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling.
The Journal of allergy and clinical immunology 2008;122(3):617-24.e6.
2008: Harsha H Kariyawasam; Georgina Xanthou; Julia Barkans; Maxine Aizen; A Barry Kay; Douglas S Robinson
Basal expression of bone morphogenetic protein receptor is reduced in mild asthma.
American journal of respiratory and critical care medicine 2008;177(10):1074-81.
2007: Harsha H Kariyawasam; Douglas S Robinson
The role of eosinophils in airway tissue remodelling in asthma.
Current opinion in immunology 2007;19(6):681-6.
2007: Andrew Menzies-Gow; Patrick Flood-Page; Douglas S Robinson; A Barry Kay
Effect of inhaled interleukin-5 on eosinophil progenitors in the bronchi and bone marrow of asthmatic and non-asthmatic volunteers.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2007;37(7):1023-32.
2007: Harsha H Kariyawasam; M Aizen; A Barry Kay; Douglas S Robinson
Safety and tolerability of three consecutive bronchoscopies after allergen challenge in volunteers with mild asthma.
Thorax 2007;62(6):557-8.
2007: Clare M Lloyd; Douglas S Robinson
Allergen-induced airway remodelling.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2007;29(5):1020-32.
2007: Harsha H Kariyawasam; Maxine Aizen; Julia Barkans; Douglas S Robinson; A Barry Kay
Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma.
American journal of respiratory and critical care medicine 2007;175(9):896-904.
2006: Leonie S Taams; Donald B Palmer; Arne N Akbar; Douglas S Robinson; Zarin Brown; Catherine M Hawrylowicz
Regulatory T cells in human disease and their potential for therapeutic manipulation.
Immunology 2006;118(1):1-9.
2006: Harsha H Kariyawasam; Douglas S Robinson
The eosinophil: the cell and its weapons, the cytokines, its locations.
Seminars in respiratory and critical care medicine 2006;27(2):117-27.
2006: Emmanuel Xystrakis; Siddharth Kusumakar; Sandra Boswell; Emma Peek; Zoë Urry; David F Richards; Tonye Adikibi; Carol Pridgeon; Margaret Dallman; Tuck-Kay Loke; Douglas S Robinson; Franck J Barrat; Anne O'Garra; Paul Lavender; Tak H Lee; Christopher J Corrigan; Catherine M Hawrylowicz
Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients.
The Journal of clinical investigation 2006;116(1):146-55.
2005: Jennifer Kearley; Jane E Barker; Douglas S Robinson; Clare M Lloyd
Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent.
The Journal of experimental medicine 2005;202(11):1539-47.
2005: David J Ahern; Douglas S Robinson
Regulatory T cells as a target for induction of immune tolerance in allergy.
Current opinion in allergy and clinical immunology 2005;5(6):531-6.
2005: Douglas S Robinson
The role of regulatory T lymphocytes in asthma pathogenesis.
Current allergy and asthma reports 2005;5(2):136-41.
2005: Harsha H Kariyawasam; Douglas S Robinson
Airway remodelling in asthma: models and supermodels?
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2005;35(2):117-21.
2004: Simon Phipps; Farid Benyahia; Tsan-Teng Ou; Julia Barkans; Douglas S Robinson; A Barry Kay
Acute allergen-induced airway remodeling in atopic asthma.
American journal of respiratory cell and molecular biology 2004;31(6):626-32.
2004: Douglas S Robinson; Mark Larché; Stephen R Durham
Tregs and allergic disease.
The Journal of clinical investigation 2004;114(10):1389-97.
2004: T R F Smith; C Alexander; A Barry Kay; Mark Larché; Douglas S Robinson
Cat allergen peptide immunotherapy reduces CD4(+) T cell responses to cat allergen but does not alter suppression by CD4(+) CD25(+) T cells: a double-blind placebo-controlled study.
Allergy 2004;59(10):1097-101.
2004: A Barry Kay; Simon Phipps; Douglas S Robinson
A role for eosinophils in airway remodelling in asthma.
Trends in immunology 2004;25(9):477-82.
2004: X Dao Nguyen; Douglas S Robinson
Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism.
The Journal of allergy and clinical immunology 2004;114(2):296-301.
2004: Douglas S Robinson
The role of the mast cell in asthma: induction of airway hyperresponsiveness by interaction with smooth muscle?
The Journal of allergy and clinical immunology 2004;114(1):58-65.
2004: Eleanor M Ling; Trevor Smith; X Dao Nguyen; Carol Pridgeon; Margaret Dallman; Justine Arbery; Victoria A Carr; Douglas S Robinson
Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease.
Lancet 2004;363(9409):608-15.
2004: Douglas S Robinson
T-cell cytokines: what we have learned from human studies.
Paediatric respiratory reviews 2004;5 Suppl A():S53-8.
2003: Miles E Banwell; Douglas S Robinson; Clare M Lloyd
Adenoid-derived TH2 cells reactive to allergen and recall antigen express CC chemokine receptor 4.
The Journal of allergy and clinical immunology 2003;112(6):1155-61.
2003: Douglas S Robinson
New therapies for asthma: where next?
Pediatric pulmonology 2003;36(5):369-75.
2003: Douglas S Robinson; D A Campbell; Stephen R Durham; J Pfeffer; Peter J Barnes; K Fan Chung
Systematic assessment of difficult-to-treat asthma.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2003;22(3):478-83.
2003: Bernard Gregory; Antje Kirchem; Simon Phipps; Phillipe Gevaert; Carol Pridgeon; Sara M Rankin; Douglas S Robinson
Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(11):5359-66.
2003: Andrew Menzies-Gow; Patrick Flood-Page; Roma Sehmi; John Burman; Qutayba Hamid; Douglas S Robinson; A Barry Kay; Judah A Denburg
Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics.
The Journal of allergy and clinical immunology 2003;111(4):714-9.
2003: Mark Larché; Douglas S Robinson; A Barry Kay
The role of T lymphocytes in the pathogenesis of asthma.
The Journal of allergy and clinical immunology 2003;111(3):450-63; quiz 464.
2003: Patrick Flood-Page; Andrew Menzies-Gow; A Barry Kay; Douglas S Robinson
Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway.
American journal of respiratory and critical care medicine 2003;167(2):199-204.
2002: Douglas S Robinson; Anne O'Garra
Further checkpoints in Th1 development.
Immunity 2002;16(6):755-8.
2002: Sun Ying; Qiu Meng; A Barry Kay; Douglas S Robinson
Elevated expression of interleukin-9 mRNA in the bronchial mucosa of atopic asthmatics and allergen-induced cutaneous late-phase reaction: relationships to eosinophils, mast cells and T lymphocytes.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2002;32(6):866-71.
2002: Douglas S Robinson; Clare M Lloyd
Asthma: T-bet--a master controller?
Current biology : CB 2002;12(9):R322-4.
2002: Andrew Menzies-Gow; Douglas S Robinson
Eosinophils, eosinophilic cytokines (interleukin-5), and antieosinophilic therapy in asthma.
Current opinion in pulmonary medicine 2002;8(1):33-8.
2002: Douglas S Robinson; A Barry Kay; Andrew J Wardlaw
Eosinophils.
Clinical allergy and immunology 2002;16():43-75.
2001: Andrew Menzies-Gow; Douglas S Robinson
Eosinophil chemokines and chemokine receptors: their role in eosinophil accumulation and activation in asthma and potential as therapeutic targets.
The Journal of asthma : official journal of the Association for the Care of Asthma 2001;38(8):605-13.
2001: BM Haselden; Mark Larché; Qiu Meng; K Shirley; R Dworski; Allen P Kaplan; C Bates; Douglas S Robinson; Sun Ying; A Barry Kay
Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid.
The Journal of allergy and clinical immunology 2001;108(3):394-401.
2001: Douglas S Robinson; D Campbell; Peter J Barnes
Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
Lancet 2001;357(9273):2007-11.
2001: Mark Larché; BM Haselden; William L G Oldfield; K Shirley; J North; Qiu Meng; Douglas S Robinson; Sun Ying; A Barry Kay
Mechanisms of T cell peptide epitope-dependent late asthmatic reactions.
International archives of allergy and immunology 2001;124(1-3):272-5.
2000: K Zeibecoglou; Sun Ying; Qiu Meng; A Barry Kay; Douglas S Robinson; Nikos Papageorgiou
Expression of eotaxin in induced sputum of atopic and nonatopic asthmatics.
Allergy 2000;55(11):1042-8.
2000: K Zeibecoglou; Sun Ying; Qiu Meng; L W Poulter; Douglas S Robinson; A Barry Kay
Macrophage subpopulations and macrophage-derived cytokines in sputum of atopic and nonatopic asthmatic subjects and atopic and normal control subjects.
The Journal of allergy and clinical immunology 2000;106(4):697-704.
2000: Douglas S Robinson
Allergen immunotherapy: does it work and, if so, how and for how long?
Thorax 2000;55 Suppl 1():S11-4.
2000: Andrew Menzies-Gow; Douglas S Robinson
Eosinophil chemokines and their receptors: an attractive target in asthma?
Lancet 2000;355(9217):1741-3.
2000: Jan Tavernier; José Van der Heyden; Annick Verhee; G Brusselle; X Van Ostade; Joël Vandekerckhove; J North; Sara M Rankin; A B Kay; Douglas S Robinson
Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit.
Blood 2000;95(5):1600-7.
2000: Douglas S Robinson
Th-2 cytokines in allergic disease.
British medical bulletin 2000;56(4):956-68.
2000: AJ Macfarlane; Onn Min Kon; S J Smith; K Zeibecoglou; LN Khan; LT Barata; Alan R McEuen; Mark G Buckley; Andrew F Walls; Qiu Meng; M Humbert; Neil C Barnes; Douglas S Robinson; Sun Ying; A Barry Kay
Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin.
The Journal of allergy and clinical immunology 2000;105(1 Pt 1):99-107.
1999: Sun Ying; Qiu Meng; K Zeibecoglou; Douglas S Robinson; A Macfarlane; M Humbert; A Barry Kay
Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(11):6321-9.
1999: Sun Ying; Douglas S Robinson; Qiu Meng; LT Barata; Alan R McEuen; Mark G Buckley; Andrew F Walls; Philip W Askenase; A Barry Kay
C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
Journal of immunology (Baltimore, Md. : 1950) 1999;163(7):3976-84.
1999: K Zeibecoglou; AJ Macfarlane; Sun Ying; Qiu Meng; Ian D Pavord; Neil C Barnes; Douglas S Robinson; A Barry Kay
Increases in eotaxin-positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challenge.
Allergy 1999;54(7):730-5.
1999: Douglas S Robinson; J North; K Zeibecoglou; Sun Ying; Qiu Meng; S Rankin; Qutayba Hamid; J Tavernier; A Barry Kay
Eosinophil development and bone marrow and tissue eosinophils in atopic asthma.
International archives of allergy and immunology 1999;118(2-4):98-100.
1999: K Zeibecoglou; Sun Ying; T Yamada; J North; J Burman; JK Bungre; Qiu Meng; A Barry Kay; Douglas S Robinson
Increased mature and immature CCR3 messenger RNA+ eosinophils in bone marrow from patients with atopic asthma compared with atopic and nonatopic control subjects.
The Journal of allergy and clinical immunology 1999;103(1 Pt 1):99-106.
1999: Douglas S Robinson; R Damia; K Zeibecoglou; S Molet; J North; T Yamada; A Barry Kay; Qutayba Hamid
CD34(+)/interleukin-5Ralpha messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors.
American journal of respiratory cell and molecular biology 1999;20(1):9-13.
1998: Mark Larché; Stephen Till; BM Haselden; J North; Julia Barkans; Christopher J Corrigan; A Barry Kay; Douglas S Robinson
Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(11):6375-82.
1998: T Yamada; Q Sun; K Zeibecoglou; JK Bungre; J North; A Barry Kay; A F Lopez; Douglas S Robinson
IL-3, IL-5, granulocyte-macrophage colony-stimulating factor receptor alpha-subunit, and common beta-subunit expression by peripheral leukocytes and blood dendritic cells.
The Journal of allergy and clinical immunology 1998;101(5):677-82.
1998: G Menz; Sun Ying; Stephen R Durham; Christopher J Corrigan; Douglas S Robinson; Q Hamid; R Pfister; M Humbert; A Barry Kay
Molecular concepts of IgE-initiated inflammation in atopic and nonatopic asthma.
Allergy 1998;53(45 Suppl):15-21.
1997: Sun Ying; Douglas S Robinson; Qiu Meng; J Rottman; R Kennedy; Douglas J Ringler; CR Mackay; Bruce L Daugherty; Martin S Springer; Stephen R Durham; Timothy J Williams; A Barry Kay
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells.
European journal of immunology 1997;27(12):3507-16.
1997: Sun Ying; Qiu Meng; LT Barata; Douglas S Robinson; Stephen R Durham; A Barry Kay
Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(10):5050-7.
1997: Sun Ying; M Humbert; Julia Barkans; Christopher J Corrigan; R Pfister; G Menz; Mark Larché; Douglas S Robinson; Stephen R Durham; A Barry Kay
Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(7):3539-44.
1996: Douglas S Robinson
Allergen-induced airways inflammation in asthma.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 1996;51(6):469-74.
1996: Douglas S Robinson; Duncan M Geddes; David Hansell; C D Shee; Cathy Corbishley; AJ Murday; Brendan P Madden
Partial resolution of acute interstitial pneumonia in native lung after single lung transplantation.
Thorax 1996;51(11):1158-9; discussion 1164-9.
1996: M Humbert; Stephen R Durham; Sun Ying; P Kimmitt; Julia Barkans; B Assoufi; R Pfister; G Menz; Douglas S Robinson; A Barry Kay; Christopher J Corrigan
IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity.
American journal of respiratory and critical care medicine 1996;154(5):1497-504.
1996: M Humbert; Douglas S Robinson; B Assoufi; A Barry Kay; Stephen R Durham
Safety of fibreoptic bronchoscopy in asthmatic and control subjects and effect on asthma control over two weeks.
Thorax 1996;51(7):664-9.
1996: Douglas S Robinson; A Tsicopoulos; Qiu Meng; S Durham; A Barry Kay; Qutayba Hamid
Increased interleukin-10 messenger RNA expression in atopic allergy and asthma.
American journal of respiratory cell and molecular biology 1996;14(2):113-7.
1996: A M Bentley; Qutayba Hamid; Douglas S Robinson; E Schotman; Qiu Meng; B Assoufi; A Barry Kay; Stephen R Durham
Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa.
American journal of respiratory and critical care medicine 1996;153(2):551-6.
1995: Douglas S Robinson; B Assoufi; Stephen R Durham; A Barry Kay
Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1995;25(11):1118-27.
1993: A M Bentley; Stephen R Durham; Douglas S Robinson; G Menz; C Storz; O Cromwell; A Barry Kay; A J Wardlaw
Expression of endothelial and leukocyte adhesion molecules interacellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma.
The Journal of allergy and clinical immunology 1993;92(6):857-68.
1993: A Hartnell; Douglas S Robinson; A Barry Kay; A J Wardlaw
CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines.
Immunology 1993;80(2):281-6.
1993: Douglas S Robinson; Sun Ying; A M Bentley; Qiu Meng; J North; Stephen R Durham; A Barry Kay; Qutayba Hamid
Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma.
The Journal of allergy and clinical immunology 1993;92(3):397-403.
1993: Douglas S Robinson; Stephen R Durham; A Barry Kay
Cytokines. 3. Cytokines in asthma.
Thorax 1993;48(8):845-53.
1993: Douglas S Robinson; A M Bentley; A Hartnell; A Barry Kay; Stephen R Durham
Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness.
Thorax 1993;48(1):26-32.
1993: A M Bentley; Qiu Meng; Douglas S Robinson; Qutayba Hamid; A Barry Kay; Stephen R Durham
Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics.
American journal of respiratory cell and molecular biology 1993;8(1):35-42.
1993: Douglas S Robinson; Qutayba Hamid; M Jacobson; Sun Ying; A Barry Kay; Stephen R Durham
Evidence for Th2-type T helper cell control of allergic disease in vivo.
Springer seminars in immunopathology 1993;15(1):17-27.
1992: A M Bentley; G Menz; C Storz; Douglas S Robinson; B Bradley; Peter K Jeffery; Stephen R Durham; A Barry Kay
Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness.
The American review of respiratory disease 1992;146(2):500-6.
1992: V A Varney; Mikila R Jacobson; R M Sudderick; Douglas S Robinson; A M Irani; L B Schwartz; Ian S Mackay; A Barry Kay; Stephen R Durham
Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils.
The American review of respiratory disease 1992;146(1):170-6.
1992: Qutayba Hamid; Julia Barkans; Douglas S Robinson; Stephen R Durham; A Barry Kay
Co-expression of CD25 and CD3 in atopic allergy and asthma.
Immunology 1992;75(4):659-63.
1992: A M Bentley; P Maestrelli; M Saetta; L M Fabbri; Douglas S Robinson; B L Bradley; Peter K Jeffery; Stephen R Durham; A Barry Kay
Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma.
The Journal of allergy and clinical immunology 1992;89(4):821-9.
1992: Douglas S Robinson; Qutayba Hamid; Sun Ying; A Tsicopoulos; Julia Barkans; A M Bentley; Christopher J Corrigan; Stephen R Durham; A Barry Kay
Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.
The New England journal of medicine 1992;326(5):298-304.
1991: Sun Ying; Douglas S Robinson; V Varney; Qiu Meng; A Tsicopoulos; Redwan Moqbel; Stephen R Durham; A Barry Kay; Qutayba Hamid
TNF alpha mRNA expression in allergic inflammation.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1991;21(6):745-50.